Shoulder Pericapsular Block Versus Interscalene Block in Arthroscopic Shoulder Surgery
Condition(s) studied
Investigational drug(s) / intervention(s)
Interscalene Nerve Block: Procedure: Ultrasound-guided conventional intrafascial interscalene block at C5-C6 level Drug: 15 mL of 0.25% bupivacaine (37.5 mg)
shoulder pericapsular nerve group block: Procedure: Ultrasound-guided shoulder pericapsular nerve group block Drug: 15 mL of 0.25% bupivacaine (37.5 mg)
Study summary
This randomized controlled trial aims to compare the incidence of hemidiaphragmatic paralysis (HDP) following ultrasound-guided interscalene block (ISB) versus shoulder pericapsular nerve group (PENG) block in patients undergoing elective shoulder surgery under general anesthesia.
The primary objective is to determine whether the shoulder PENG block reduces the incidence of HDP compared with conventional intrafascial ISB. HDP will be assessed using ultrasound measurement of diaphragmatic excursion 30 minutes after block performance
Eligibility
Primary outcome measure(s)
- Hemidiaphragmatic Paralysis (HDP) — 30 minutes after block performance
≥25% reduction in diaphragmatic excursion from baseline measured by ultrasound M-mode.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Marmara University | Istanbul | Turkey (Türkiye) | Recruiting |
More Marmara University trials in Turkey
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07486349 on ClinicalTrials.gov ↗ ← All trials in Turkey